RIVUNATPAGENE MIZIPARVOVEC

UNII:	24Q8LJQ6Y2
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RIVUNATPAGENE MIZIPARVOVEC
GSRS Full Record:	24Q8LJQ6Y2 i

2646715-00-4
DNA (recombinant replication-defective adeno-associated virus serotype 9 vector UX701 murine transthyretin enhancer plus human transthyretin promoter plus simian virus 40 intron plus human adenosine triphosphatase copper-transporting β metal-binding domain 4/5/6 transgene ATP7B-MBD456 plus simian virus 40 polyadenylation signal plus adeno-associated virus 2 inverted terminal repeat flanks plus adeno-associated virus 2 Rep region plus adeno-associated virus 9 Cap region-specifying)
RIVUNATPAGENE MIZIPARVOVEC [USAN]
Rivunatpagene Miziparvovec
UX-701
UX701
recombinant, non-replicating adeno-associated virus serotype 9 (rAAV9) vector encoding ATPase copper-transporting beta gene (ATP7B, copper transporting ATPase 2), modified to encode the last three of the six metal-binding domains (ATP7B-MBD456), under control of a murine transthyretin enhancer/human transthyretin promoter, with a simian virus 40 (SV40) intron, terminated with an SV40 polyadenylation signal, and flanked by adeno-associated virus 2 (AAV2) inverted terminal repeats (ITRs)
rivunatpagene miziparvovec [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RIVUNATPAGENE MIZIPARVOVEC

Synonyms and Mappings

Resources